Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma”.
Natalia Díaz‐Valdivia, Marta Gabasa, Rafael Ikemori, Marselina Arshakyan, Patricia Fernández‐Nogueira +11 more
Juan Carlos García‐Cañaveras, Marta-Leonor Rodríguez, J.H.R. Becker, A. López, Miguel Aupí +23 more